# Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?

> **NCT03901170** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Investigative Techniques
- Reproductive Techniques
- Reproductive Techniques, Assisted

## Interventions

- **DRUG:** Letrozole 2.5mg

## Key facts

- **NCT ID:** NCT03901170
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-25
- **Primary completion:** 2020-06-30
- **Final completion:** 2021-04-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901170, "Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03901170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*